- Open Access
Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran
Gut Pathogens volume 11, Article number: 2 (2019)
The emergence of colistin-resistant Enterobacteriaceae from human and animal sources is a public health concern as this antibiotic is considered to be the last line therapeutic option for infections caused by multidrug-resistant Gram-negative bacteria. Here we aimed to determine the prevalence of colistin resistance, among enterobacteria isolated from poultry and the possible underlying colistin resistance mechanisms.
A collection of 944 cloacal samples were obtained from poultry and screened for colistin resistance. To uncover the molecular mechanism behind colistin resistance, the presence of plasmid encoded colistin resistance genes mcr-1, mcr-2, mcr-3 and mcr-4 was examined by PCR. The nucleotide sequences of the mgrB, pmrA, pmrB, phoP, phoQ, crrA and crrB genes were determined. The genetic relatedness of the colistin resistant (ColR) isolates was evaluated by Multilocus sequence typing. Three ColR mutants were generated in vitro by repetitive drug exposure.
Overall from 931 enteric bacteria isolated from poultry samples obtained from 131 farms, nine ColR bacteria (0.96%) with high level colistin resistance (MICs ≥ 64 mg/L) were detected all being identified as K. pneumoniae. The 9 ColR bacteria originated from different farms and belonged to 7 distinct Sequence types including ST11 (22.2%) and ST726 (22.2%) being the most prevalent STs followed by ST37, ST74, ST485, ST525 and novel sequence type 3380 (11.1% each). mcr-type genes were not detected in any isolate. In 88.8% of the isolates (n = 8), MgrB was inactivated by Insertion of IS elements (IS1-like, IS3-like, IS5-like families, positions + 75, + 113, + 117, + 135) and nonsense mutations at codons 8, 16, 30. All ColR isolates harboured wild type PmrA, PhoP, PhoQ or polymorphic variants of PmrB. Sequence analysis of the CrrB revealed a familiar S195N and 4 novel I27V, T150R, F303S and K325R substitutions. PmrB T93N substitution and mgrB locus deletion were identified in two laboratory induced ColR mutants and one mutant lacked alteration in the studied loci. In one ColR isolate with wild type MgrB an A83V substitution was detected in CrrA.
It is concluded from our results that colistin resistance in the studied avian K. pneumoniae isolates was mostly linked to alterations identified within the mgrB gene.
Antibiotic resistance (ABR) rate has reached emergency levels both in human and veterinary medicine with many countries recognizing it as an important emerging threat to global public health and food safety. The agricultural use of human antibiotics as growth promoters or as prophylactic agents in farm animals has been criticized for contributing to the magnitude of the global challenge of ABR . This is considered as a potential threat to human health as commensal resistant organisms propagated in food-producing animals can be transmitted to humans indirectly along the food chain or following direct contact or may serve as reservoirs of transferable antibiotic resistance determinants that could be transferred to human pathogens [1, 2]. For example, evidence supporting transmission of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli clones, from livestock to human being presumably through the food chain . Among the veterinary critically important antimicrobial agents is colistin -a last resort agent for treating multidrug-resistant (MDR) infections in humans- which is used mainly in poultry farms for prevention and treatment of Enterobacteriaceae infections . Although not frequently used in human medicine, emergence of extensively drug-resistant (XDR) Gram-negatives bacteria (GNB), in clinical setting and paucity of novel marketed antibiotics, has led to the renewed interests in colistin for management of severe infections caused by these pathogens . Polymyxins (polymyxin B and colistin) are bactericidal cationic antimicrobial peptides that exert their antibacterial effect mainly by disruption of outer membrane in GNB . Resistance to this last-hope group of antimicrobials was recently detected among the members of Enterobacteriaceae in animals, retail meat and humans in china and subsequently reported by many regions of the world . The most common mechanism of resistance among Enterobacteriaceae includes covalent modification of lipopolysaccharide (LPS) target through incorporation of positively charged groups. This alteration neutralizes the negative charges of the LPS and reduces binding affinity of cationic colistin to its target. LPS modifications in Klebsiella pneumoniae are known to be mediated mainly by genetic alterations in two component regulatory systems including PmrAB, CrrAB, PhoPQ or the negative feedback regulator of PhoPQ signaling system, MgrB [8,9,10,11]. Moreover, acquisition of plasmid encoded mcr-type genes, which encode enzymes able to modify LPS by the addition of phosphoethanolamine has been found to contribute in colistin resistance in most of the E. coli, Salmonella and some K. pneumoniae isolates [7, 12, 13].
Despite the fact that colistin has been widely used in veterinary medicine notably in poultry in Iran, little is known about the prevalence of colistin resistance and mcr genes among the commensal enteric bacterial isolates from food-producing animals in this geographic region. This study aimed to investigate the frequency of colistin resistance among commensal enteric bacteria isolated from poultry and to determine the possible underlying mechanisms among colistin-resistant isolates.
Screening for colistin resistant (ColR) enteric bacteria
A total of 944 laying hens and broilers as well as turkeys were studied between September 2017 to July 2018. Cloacal swabs were taken randomly from poultry referred to poultry diagnostic center (those with viral or metabolic diseases) of the northwest of Iran or from healthy broilers at one major chicken slaughterhouse (with process capacity of 25,000–40,000 chickens per day) located in Tabriz city, East Azerbaijan province. About 15 or three to five samples per farm were collected from the slaughterhouse or poultry disease clinic respectively and analyzed. The obtained samples (using sterile cotton swabs) were seeded on Eosin Methylene Blue (EMB) agar plates and were incubated at 37 °C for 24 h. All of the grown isolates were preliminary screened by inoculating the isolates into Mueller–Hinton broth (MHB) supplemented with colistin as follow: a suspension of the organism to be tested was prepared by suspending colonies from an overnight culture into the sterile MHB. The density of the suspension was measured with an Eppendorf Biophotometer and adjusted to OD600 of 0.085 (equivalent to the turbidity of a 0.5 McFarland standard). Three microliter of the prepared suspension were inoculated into two glass tubes containing 597 μL MHB supplemented with 2 and 4 mg/L colistin respectively to yield a final inoculum of ca. 5 × 105 CFU/mL. The tubes were incubated in air at 37 °C for 16 to 20 h. An aliquot of 10 μL from all tubes in which visible bacterial growth was observed were seeded on EMB agar plates supplemented with 3 mg/L colistin which were then incubated for overnight at 37 °C. The isolated ColR bacteria were identified using conventional biochemical methods and were further tested for susceptibility to colistin by broth macrodilution method, whereby a minimum inhibitory concentration (MIC) of > 2 mg/L was considered indicative of colistin resistance according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) . Colistin susceptible (ColS) Pseudomonas aeruginosa ATCC27853, K. pneumoniae ATCC 700603 and E. coli ATCC25922 were used as quality control for colistin susceptibility testing.
Testing susceptibility to other antimicrobials
The susceptibility of the ColR isolates to various classes of antibiotics was determined by disk diffusion method (Kirby Bauer) according to the Clinical and Laboratory Standards Institute (CLSI (M100-S27)  guidelines using the following antibiotics: gentamicin, amikacin, ceftriaxone, ceftazidime, ceftazidime-clavulanate, imipenem, ciprofloxacin, levofloxacin, doxycycline, and fosfomycin (BBL Sensi-Disc™, Becton–Dickinson, Sparks, MD).
Genotyping by multilocus sequence typing
Multilocus sequence typing (MLST) was carried out with seven standard housekeeping genes (rpoB, gapA, mdh, pgi, phoE, infB and tonB) according to method of Diancourt et al. . Allele sequences and sequence types (STs) were analyzed by using the K. pneumoniae MLST database provided by the Institut Pasteur, Paris, Franc (http://bigsdb.pasteur.fr/klebsiella/klebsiella.html). To investigate the evolutionary relationship among our ColR isolates, BioNumerics (version 7.6.3; Applied Maths, Sint-Martens-Latem, Belgium) was used to construct a minimum spanning tree based on the MLST profiles.
Identification of colistin resistance determinants
The chromosomal Deoxyribonucleic acid (DNA) of the avian isolates was extracted by the boiling method (https://www.eurl-ar.eu/CustomerData/Files/Folders/21-protocols/278_mcr-multiplex-pcr-protocol-v2-oct16.pdf) and were subjected for polymerase chain reaction (PCR) amplification of the genes encoding the PmrA, PmrB, MgrB, PhoP, PhoQ, CrrA and CrrB proteins using primers described previously  (primers pmrB-F1 and pmrB-R2 were used for PmrB). For amplification of mgrB locus two pairs of primers were used: (i) mgrB-F and mgrB-R (external to mgrB) targeting amplification of mgrB coding sequence as well as some flanking regions  (ii) Int_mgrB_F (5′-CGGTGGGTTTTACTGATAGTCA-3′) and Int_mgrB_R (5′-ATAGTGCAAATGCCGCTGA-3′) targeting amplification of an internal region of the mgrB coding sequence (used with some strains) . The primers used for amplification of entire crrA and crrB genes were as follows: CrrA-F (5′-GCATGTTGTCATCAGCACTGTG-3′) and CrrA-R (5′-GGAACCGAGTATTGCAATGG-3′), CrrB-F (5′-GGATTGAAGGGCATTCCGGA-3′) and CrrB-R (5′-GCAGTATGTGGGATCTGTCT-3′). The PCR products were sequenced and the nucleotides and deduced protein sequences were analyzed at the National Center for Biotechnology Information web site. In addition, the pmrA, pmrB, mgrB, phoP, phoQ, crrA and crrB sequences of two ColS K. pneumoniae isolates obtained from healthy broilers in slaughterhouse were determined as wild-type controls. The IS Finder database (https://www-is.biotoul.fr/) was used to identify and analyze insertion sequences. Identified novel amino acid substitutions were further analyzed by using the Protein Variation Effect Analyzer tool (PROVEAN) (http://provean.jcvi.org/index.php) to predict their impact on the biological function of the protein (i.e. neutral or deleterious) . All ColR isolates were also screened for the presence of plasmid encoded colistin resistance genes mcr-1, mcr-2, mcr-3 and mcr-4 genes by PCR as described previously [7, 13, 20, 21].
Laboratory induction of colistin resistance
To assess whether colistin non-susceptibility occurs after colistin exposure, an in vitro resistance induction experiment was performed by exposing two ColS isolates obtained from healthy broilers to elevated concentrations of colistin. The EMB agar plates supplemented with 2 mg/L colistin were inoculated with 3 × 105 CFU/mL CloS bacterial suspension and were incubated for 48–72 h. Colonies growing on each plate were picked and subcultured on media with the same or increasing colistin concentration (5, 7, 10, 20, 50 mg/L). Colistin MIC and susceptibility to other antibiotics in the selected mutants were determined by broth macrodilution and disk diffusion methods respectively.
Bacterial screening, antimicrobial susceptibility testing and bacterial genotyping
Overall 944 samples were collected from 131 farms located in 29 different cities of the East Azerbaijan province which included 503 samples from healthy broilers at slaughterhouse and 441 samples from dead poultry referred to clinic during 2017–2018 (Table 1). A total of 931 isolated enteric bacteria (495 and 436 isolates from slaughterhouse and clinic respectively) were screened for colistin resistance according to cut off point of > 2 mg/L as defined by EUCAST. Overall, nine ColR enteric bacteria with MIC > 2 mg/L were detected all being identified as K. pneumoniae according to biochemical methods (excluding the number of Proteus spp. (n = 146) which are intrinsically resistant to polymyxins). All ColR isolates were characterized with high level colistin resistance with MICs ≥ 64 mg/L. The nine ColR K. pneumoniae (CRKP) isolates originated from different farms and belonged to 7 distinct Sequence types including ST11 (22.2%) and ST726 (22.2%) being the most prevalent STs followed by ST37, ST74, ST485, ST525 and novel sequence type 3380 (11.1% each) (Fig. 1). About 88.8% (n = 8) of ColR isolates showed resistance to at least one tested antimicrobial agent, including doxycycline (n = 8, 88.8%), levofloxacin (n = 7, 77.7%), ciprofloxacin (n = 7, 77.7%), gentamicin (n = 3, 33.3% resistant and n = 2, 22.2% with intermediate susceptibility) and fosfomycin (n = 1, 11.1%). No resistance was found for amikacin, ceftriaxone, ceftazidime and imipenem. The two ColS control K. pneumoniae isolates obtained from healthy broilers originated from different farms and cities and characterized with different colistin MIC values (0.25 and 1 mg/L). Doxycycline resistance was found in both ColS isolates among which one was characterized with, ciprofloxacin/levofloxacin and fosfomycin resistance as well. The colistin resistance induction assay was performed using these two ColS isolates to assess the contributing role of colistin exposure as a risk factor for colistin resistance emersion. The laboratory induced ColR isolate, K113R was obtained by six selection cycles in the presence of increasing concentrations of colistin. The colistin MIC of this isolate was found to be 32 mg/L which was 32 times higher than that in the progenitor ColS isolate K113S (MIC = 1 mg/L). Similarly, seven and six selection cycles were required to obtain two ColR mutants K79R1 (MIC > 128 mg/L) and K79R2 (MIC = 64 mg/L) respectively originated from a ColS isolate K79S (MIC = 0.25 mg/L). Indeed, from colonies originated form K79S grown on EMB agar supplemented with 2 mg/L colistin, two distinct colonies were picked and exposed separately to increasing colistin concentrations. Colistin resistance induction was not associated with change in susceptibility to other antimicrobials in laboratory induced ColR isolates (Table 2).
Molecular determinants of acquired colistin resistance
In order to analyze the molecular mechanisms accounting for colistin-resistance in the studied commensal enteric bacteria the presence of mcr-1, 2, 3, 4 genes were investigated in all isolates. As could be expected form the level of resistance (high), mcr-type genes were not detected in any isolate and therefore, presence of mutations in chromosomally encoded genes was suspected. Among the studied seven proteins, MgrB, a negative regulator of the PhoPQ signaling system, was the most altered protein being inactivated in 8 of 9 ColR avain isolates (88.8%). The MgrB inactivation was found to be mediated by two mechanisms: (1) insertion of IS elements belonging to 3 different families including IS1-like (768 pb bp), IS5-like [(ISEc68), 1197 bp] and IS3-like elements (1336 and 1259 bp) being inserted in different positions (+ 75, + 113, + 117, + 135) within the coding region of the protein. This inactivation mechanism was found in 4 isolates assigned to ST485, ST37, ST11 and ST74 genotypes and disrupted the coding region of mgrB and most likely mediated the resistance in these isolates (2) premature termination due to nonsense mutations at codon 30 [CAG (Gln) > TAG (Stop)], codon 8 [TTA (Leu) > TAA (Stop)] and codon 16 [TGC (Cys) > TGA (Stop)]. Moreover, a cytosine deletion at position + 25 was observed in MgrB harboring L8Stop substitution immediately after codon8, resulting in frame shifting and creation of the second and third stop codons TGA and TAG after codon 8. These nonsense mutations were observed in 4 isolates belonging to sequence types ST3380 (n = 1), ST525 (n = 1), ST726 (n = 2) and resulted in production of truncated proteins with 7, 15 and 29 amino acids instead of 47 amino acid wild-type MgrB. One ColR isolate with high level colistin resistance (MIC > 128 mg/L) assigned to ST11 carried a wild type MgrB and revealed a CrrA A83V (GCA > GTA) substitution as the only alteration in the studied genes. All ColR isolates revealed wild type pmrA, phoP, and phoQ genes. Sequence analysis of the CrrB revealed a common resistance conferring S195N (AGT > AAT) substitution and 4 novel amino-acid changes [I27V (ATA > GTA), T150R (ACG > AGG), F303S (TTT > TCT) and K325R (AAA > AGG)] in ColR K. pneumoniae isolates. PmrB R256G (CGC > GGC) and A246T (GCC > ACC) substitutions were also found in 8 ColR isolates. While all ColS isolates harbored wild type MgrB, PhoP, PhoQ, PmrA and CrrA, one isolate had a R256G mutated PmrB and the other had K325R substitution in the CrrB. In search of the altered gene in the laboratory induced ColR isolate K113R, during the repetitive exposure experiment, we found a novel T93N (ACC > AAC) substitution in the PmrB compared to ColS parent isolate. The isolate carried a wild type MgrB, PhoP, PhoQ, PmrA, CrrA and a K325R mutated CrrB similar to the progenitor ColS isolate (Table 2). More interestingly in laboratory induced ColR K79R1, which was characterized with > 512 times increase in colistin MIC after the induction assay, no amplification product was obtained using the external mgrB primers suggesting deletion of the mgrB locus. The absence of mgrB in the genome of this mutant was confirmed by PCR using the internal mgrB primers as described previously . In ColR K79R2 isolate, no substitution was identified in the studied genes suggesting possible involvement of other unknown gene(s) in addition to the studied loci in conferring colistin resistance. While the PROVEAN prediction of the amino acid changes showed that PmrB T93N, CrrB F303S, T150R and CrrA A83V substitutions could have deleterious impact on the function of the corresponding proteins, CrrB K325R and I27V substitutions were categorized as neutral changes (Table 3).
Nucleotide sequence accession numbers
The nucleotide sequences of the mutated/altered mgrB, crrB, pmrB and crrA genes have been deposited at GenBank nucleotide sequence database under accession numbers MH990333 to MH990347.
The subtherapeutic application of antibiotics as prophylaxis or for growth promotion in farmed animals is described as a major contributor to the clinical problem of resistant disease in human medicine. There is evidence that food producing animals are likely contributor to the recent emergence of clinically important bacteria such as mcr-positive colistin resistant Enterobacteriaceae in human . Colistin is among the most commonly used veterinary antibiotics in food animals worldwide and it is widely used in Iran for prevention/treatment of digestive tract diseases in chickens. In the current work we studied the prevalence and genetic background of ColR enteric bacteria colonizing the gut of poultry from 131 chicken farms located in 29 cities of East Azerbaijan province. We introduced here an effective screening method using selective broth media for accurate identification of ColR isolates from the polymicrobial samples such as cloacal swabs. It is important to note that alongside the screening using MHB supplemented with colistin, we performed the screening using the colistin containing agar plates (supplemented with 2 and 4 mg/L colistin) as well. However, since the agar dilution method has been found to produce higher colistin MIC values compared to broth dilution method [23, 24], we confronted with large number of false resistant cases. Moreover, there were some ColR isolate cases which were missed by agar screening method but detected by broth screening method (data not shown). From the 931 screened enteric bacterial isolates, 9 (0.96%) were found to be colistin resistant which were identified as K. pneumoniae. In this study we did not find any ColR E. coli isolate. ST11 was one of the most frequent Sequence types being found in 22.2% of ColR isolates originated from different farms and characterized with diverse resistance mechanisms. This sequence type has been previously reported by several other studies as a common ST among CRKP with human origin [11, 25, 26] indicating the successful circulation of this hypervirulent CRKP among the human and animal sources. One CRKP isolate obtained from turkey was characterized with sequence type 37 which has been frequently reported from CRKP of animal origin and is found to be associated with resistance to the last-hope anti-XDR-GNB antibiotics, colistin and tigecycline [27, 28]. In a search to unravel the colistin resistant mechanisms, we found that resistance in the studied CRKP isolates was not related to plasmid-encoded colistin resistance genes mcr-1 to mcr-4. This was not a surprise for us as CRKP isolates studied here characterized with high MIC values (≥ 64 mg/L) which have been found to be caused by chromosomal alterations. On the other hand, mcr-type genes are suggested to confer a low level of colistin resistance. In 88.8% of the studied isolates, MgrB was inactivated by either insertion of IS elements or premature termination due to nonsense mutations. In four isolates belonging to sequence types ST3380, ST525 and ST726 a premature stop codon was identified in codons 8, 16 and 30 leading to production of truncated protein with 7, 15 and 29 amino acids respectively compared to wild-type MgrB (47aa). These amino acid substitutions were probably leading to production of a non-functional MgrB protein, and therefore were probably the source of colistin resistance. While Q30STOP substitution in CRKP had been previously reported by several other studies [10, 29], C16STOP and L8STOP were identified in our study as novel MgrB substitutions. In 4 isolates assigned to sequence types ST485, ST37, ST11 and ST74 mgrB was disrupted by insertion of mobile DNA belonging to three different IS1, IS3 and IS5-like families. Surprisingly, all IS elements targeted 4 different sites within the mgrB gene. Several other studies have reported interruption of mgrB by IS5, and it was found that this mobile DNA always targeted the same location, between nucleotides 74 and 75 of the mgrB sequence [10, 18]. By comparing our results to other published data, it can be concluded that nucleotide positions + 74/+ 75 and + 88 (codon 30) in mgrB might constitute a hot spot of integration for ISs belonging to the IS5 family or nonsense mutations respectively. Sequence analysis of PmrB revealed some variants including T246A and R256G in ColR isolates with the latter being also found in one ColS isolate. Since these alterations have been found in numerous ColS isolates [28, 29], they can’t contribute to colistin resistance alone and most likely correspond to polymorphisms as demonstrated previously [11, 17]. Overall, five amino acid substitutions were identified in CrrB, among which S195N had been previously described by Cheng et al. as contributing to colistin resistance . Among the remaining 4 novel substitutions, only F303S and T150R were predicted by the PROVEAN tool to have deleterious impact on protein structure. We also suggest that amino acid change K325R in CrrB cannot contribute to colistin resistance alone since this mutation was also found in a ColS isolate. This substitution was also categorized as neutral change by the PROVEAN tool. One ColR isolate with high level colistin resistance (MIC > 128 mg/L) assigning to ST11 carried a wild type MgrB, CrrB, PmrAB, PhoPQ systems, but A83V substitution was detected in CrrA which might be harmful for protein as predicted by PROVEAN tool. In the three laboratory induced ColR mutants resistance was developed in a very short time period (6 or 7 selection cycles) indicating that colistin exposure might act as an important risk factor for resistance emersion. Sequence analysis of the studied genes revealed no alteration in the case of laboratory induced ColR mutant K79R2, implying that molecular factors other than what were studied here might mediate resistance in this isolate. PmrB T93N substitution and complete deletion of mgrB locus were identified in the other two laboratory induced ColR mutants. Cannatelli et al. previously reported CRKP isolates characterized with complete mgrB locus deletion which did not yield any PCR product when amplification was performed using different primers designed for flanking or internal sequences of mgrB . Overall, whether novel changes recognized here influence colistin resistance is not known, as some have never been described before. The exact role of these novel variants in resistance conferring, require to be further studied by confirmatory tests, such as complementation assays with wild-type counterparts. However, according to previous studies demonstrating the key role of MgrB alterations in conferring colistin resistance, and observations regarding inactivation of mgrB gene in 88.8% of the avain CRKP isolates and induction of high level colistin resistance following mgrB locus deletion it can be concluded that colistin resistance in the studied avian CRKP isolates was mostly linked to alterations identified within the mgrB gene. We had previously reported MgrB inactivation as the major mechanism mediating colistin resistance in Iranian KP isolates of clinical origin indicating the fact that colistin resistance in CRKP isolates of human or animal sources is mediated by a common mechanism .
We described here occurrence of colistin resistant K. pneumoniae with high level colistin resistance among the intestinal microbiota in poultry. We found MgrB alterations as the major mediator of colistin resistance in the studied avian CRKP isolates. Although we observed a low prevalence of ColR commensal bacteria (0.96%), there is always a potential for these isolates to easily spread across the country via the food chain or direct contact. The more worrisome scenario for these isolates would be acquiring resistance to carbapenems. Developing national programs to monitor antibiotic consumption and ABR in food animals and humans, are crucial for managing the concern of ABR spread via the food chain in the country.
Gram negative bacteria
colistin resistant K. pneumoniae
multilocus sequence typing
Founou LL, Founou RC, Essack SY. Antibiotic resistance in the food chain: a developing country-perspective. Front Microbiol. 2016;7:1881.
Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl. 2015;8(3):240–7.
Kluytmans JA, Overdevest IT, Willemsen I, Kluytmans-Van Den Bergh MF, Van Der Zwaluw K, Heck M, et al. Extended-spectrum β-lactamase–producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis. 2012;56(4):478–87.
Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. Int J Antimicrob Agents. 2016;48(6):598–606.
Conly J, Johnston B. Colistin: the phoenix arises. Can J Infect Dis Med Microbiol. 2006;17(5):267–9.
Gupta S, Govil D, Kakar PN, Prakash O, Arora D, Das S, et al. Colistin and polymyxin B: a re-emergence. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2009;13(2):49.
Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–8.
Jayol A, Poirel L, Brink A, Villegas M-V, Yilmaz M, Nordmann P. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother. 2014;58(8):4762–6.
Cheng Y-H, Lin T-L, Lin Y-T, Wang J-T. Amino acid substitutions of CrrB responsible for resistance to colistin through CrrC in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2016;60(6):3709–16.
Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Turkoglu S, et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrobial Chemother. 2015;70(1):75–80.
Cheng YH, Lin TL, Pan YJ, Wang YP, Lin YT, Wang JT. Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan. Antimicrob Agents Chemother. 2015;59(5):2909–13.
Gu DX, Huang YL, Ma JH, Zhou HW, Fang Y, Cai JC, et al. Detection of Colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and Escherichia coli isolates from an infant with diarrhea in China. Antimicrob Agents Chemother. 2016;60(8):5099–100.
Carattoli A, Villa L, Feudi C, Curcio L, Orsini S, Luppi A, et al. Novel plasmid-mediated colistin resistance mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Eurosurveillance. 2017. https://doi.org/10.2807/1560-7917.ES.2017.22.31.30589.
Group C-EPBW. Recommendations for MIC determination of colistin (polymyxin E) as recommended by the joint CLSI-EUCAST Polymyxin Breakpoints Working Group. EUCAST http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_documents/Recommendations_for_MIC_determination_of_colistin_March_2016.pdf. Accessed 4 2017.
Patel JB. Performance standards for antimicrobial susceptibility testing. Wayne: Clinical and Laboratory Standards Institute; 2017.
Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178–82.
Haeili M, Javani A, Moradi J, Jafari Z, Feizabadi MM, Babaei E. MgrB alterations mediate colistin resistance in Klebsiella pneumoniae isolates from Iran. Front Microbiol. 2017;8:2470.
Cannatelli A, Giani T, D’Andrea MM, Di Pilato V, Arena F, Conte V, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–703.
Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–7.
Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Eurosurveillance. 2016;21(27):30280.
Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8(3):e00543-17.
Maamar E, Alonso CA, Hamzaoui Z, Dakhli N, Abbassi MS, Ferjani S, et al. Emergence of plasmid-mediated colistin-resistance in CMY-2-producing Escherichia coli of lineage ST2197 in a Tunisian poultry farm. Int J Food Microbiol. 2018;269:60–3.
Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol. 2001;39(1):183–90.
Hogardt M, Schmoldt S, Götzfried M, Adler K, Heesemann J. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients. J Antimicrob Chemother. 2004;54(6):1057–61.
Lomonaco S, Crawford MA, Lascols C, Timme RE, Anderson K, Hodge DR, et al. Resistome of carbapenem-and colistin-resistant Klebsiella pneumoniae clinical isolates. PLoS ONE. 2018;13(6):e0198526.
Zhang R, Dong N, Huang Y, Zhou H, Xie M, Chan EWC, et al. Evolution of tigecycline-and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract. Emerg Microb Infect. 2018;7(1):127.
Taniguchi Y, Maeyama Y, Ohsaki Y, Hayashi W, Osaka S, Koide S, et al. Co-resistance to colistin and tigecycline by disrupting mgrB and ramR with IS insertions in a canine Klebsiella pneumoniae ST37 isolate producing SHV-12, DHA-1 and FosA3. Int J Antimicrob Agents. 2017;50(5):697–8.
Wang X, Liu Y, Qi X, Wang R, Jin L, Zhao M, et al. Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative Klebsiella pneumoniae. Int J Antimicrob Agents. 2017;50(4):536–41.
Aires CAM, Pereira PS, Asensi MD, Carvalho-Assef APDA. MgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil. Antimicrob Agents Chemother. 2016;60(11):6969–72.
ZP performed the experiments, analyzed the experiment data and drafted the manuscript. MH is the corresponding author who designed the experiments, analyzed the experiment data and wrote the manuscript. AF designed the experiments and wrote the manuscript. All authors read and approved the final manuscript.
“We thank the team of curators of the Institut Pasteur MLST and whole genome MLST databases for curating the data and making them publicly available at http://bigsdb.pasteur.fr/”.
The authors certify that there is no competing interest with any financial organization regarding the materials discussed in the manuscript.
Availability of data and materials
All the data supporting the findings are presented in the manuscript.
Consent for publication
Ethical approval and consent to participate
This study was supported by University of Tabriz.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Pishnian, Z., Haeili, M. & Feizi, A. Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran. Gut Pathog 11, 2 (2019). https://doi.org/10.1186/s13099-019-0282-0
- Colistin resistance
- Food-producing animals
- Gut microbiota